As a prominent analyst predicts (eventual) drug price controls, biopharma braces for a blow while Trump balls his fist
Sometime this week, no one is sure when, President Donald Trump is expected to give his long-awaited speech on drug pricing. And a long lineup …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.
